InvestDashboard.com



Infinity Pharmaceuticals, Inc. (INFI)



$0.84
52 Week Low
$2.15
2017-04-28 15:02:45 MDT
$6.63
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $98,840,000Micro Cap (Less than $200M)
Analyst Recommendation:3Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell)
Beta: 2.63 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: 89.63%
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -22.38%
% Above 200 DayMA: 11.40%
INFI Performance 52 Weeks: -68.18%
S&P 500 Performance 52 Weeks: 13.50%
Mixed Trend. Short Term trend is down, but longer term trend is up. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
INFI underperforming S&P 500 by -81.68% the last 52 Weeks.

Profile


More Valuation

Price To Book: 1.17
Great Value. Low Price to Book means better value.
EV to EBITDA: -0.04
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders1.81% 17.28%Held by fewer than average Insiders.
% Held By Institutions104.20% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float10.73% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to EquityN/A 1.08Unknown.
Profit Margin %-160.77%-00.18% Profit Margin is less than average.
Operating Margin %-651.11%-05.28% Operating Margin less than average percent. Stock can do better than this?
Return on Equity %-33.26%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-36.77%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $813,913.04 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 1.17 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Good 5 Yr Est Growth: 89.63%

  2. Stock is Above Long Term 200DMA: 11.40%

  3. Price to Cash Ratio (1.17) is less than average. Good. Company has more cash as percentage of price than other companies.

  4. Price to Book is under 5: 1.17

CONS:
  1. Stock is Below Short Term 50DMA: -22.38%

  2. Stock underperforming S&P 500 over last 52 weeks: -81.68%

  3. Shorted more than average: 10.73%

  4. Profit Margin is negative: -160.77%

  5. Operating Margin is negative: -651.11%

  6. Return on Equity is negative: -33.26%

  7. Return on Assets is negative: -36.77%


Headlines


Stock Chart


InvestDashboard.com INFI: Infinity Pharmaceuticals, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.